Our Products
Therapeutic Areas
The product information provided below is intended for residents of South Africa only. For information in other countries, please refer to the Dr. Reddy's global website.
Dear Health Care Professional Letters (DHCPLs)
| Title | Document |
|---|---|
| Risk of Mitral and Aortic Regurgitation Associated with Use of Fluoroquinolones |  |
| Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Non-Serotonin Reuptake Inhibitors (SNRIs): Risk of Postpartum Haemorrhage | |
| Increased Risk of Subclinical Acute Interstitial Nephritis Associated with the Use of Proton Pump Inhibitors (PPIs) Leading to Acute Kidney Injury and/or Chronic Renal Failure | |
| Genotoxic Anticancer Medicines – Contraception Duration | |
| The Risk of Intrathecal Administration Error Associated with Intravenous Tranexamic Acid Injection | |
Recall Letters
| Product | Date | Document |
|---|---|---|
| Dopaquel 300 | 12 July 2023 | |